Feb 6 | News
Valeant Pharmaceuticals International, Inc. today announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to Mylan Inc.
|
Feb 2 | News
Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received tentative approval from the FDA for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg (base), 20 mg (base), 40 mg (base) and 80 mg (base).
|
Dec 19 2011 | News
Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Metoprolol Succinate Extended-release (ER) Tablets USP, 25 mg, 50 mg, 100 mg, and 200 mg.
|
Dec 12 2011 | News
Mylan Inc. today announced the appointment of John Thievon as president of Dey Pharma, L.P., Mylan's fully integrated specialty pharmaceutical business.
|
Nov 23 2011 | News
The FDA issued a warning letter to Mylan for "significant violations" of manufacturing rules identified during a February inspection of a manufacturing plant in Caguas, Puerto Rico.
|
Nov 9 2011 | News
Mylan Inc. today announced that it has entered into an agreement with Pfizer for the exclusive worldwide rights to develop, manufacture and commercialize Pfizer's generic equivalent to GlaxoSmithKline's Advair Diskus and Seretide Diskus incorporating Pfizer's proprietary dry powder inhaler delivery platform.
|
Oct 27 2011 | News
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Extended-release (ER) Tablets, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg, the generic version of Purdue Pharma's MS Contin, an opioid analgesic for moderate to severe pain management.
|
Oct 19 2011 | News
Mylan Inc. today announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Warner Chilcott resolving litigation related to Femcon Fe Chewable Tablets, known generically as Norethindrone and Ethinyl Estradiol Tablets USP
|
Oct 10 2011 | News
MORGANTOWN, W.Va. (AP) — Milan "Mike" Puskar, the co-founder and former chairman of generic drug maker Mylan Inc. and a philanthropist who gave tens of millions of dollars to West Virginia University, died Friday night at home after battling cancer. He was 77.
|
Sep 20 2011 | News
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) through the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine / Tenofovir Disoproxil Fumarate Tablets, 300 mg/300 mg, co-packaged with Nevirapine Tablets, 200 mg.
|